SCHEMBL17099581

SCHEMBL17099581

NC(=O)CC(c1ccc2cn[nH]c2c1)c1ccccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.40
CTNNB1 P35222 2/20 0.40
WNT3A P56704 2/20 0.40
SYK P43405 2/20 0.40
F11 P03951 1/20 0.40
MAPK1 P28482 2/20 0.39
HTR2B P41595 1/20 0.39
RAB9A P51151 3/20 0.37
KDR P35968 2/20 0.37
ALDH1A1 P00352 2/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MKNK2 Q9HBH9 3/20 0.37
MKNK1 Q9BUB5 2/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 2/20 0.37
GAA P10253 1/20 0.37
PLK4 O00444 1/20 0.37
CHEK1 O14757 1/20 0.37
MAPK13 O15264 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17441037 0.82 SYK (0.42) FGFR1CTNNB1WNT3ASYKF11
SCHEMBL17440610 0.81 FGFR1 (0.41) FGFR1CTNNB1WNT3AMAPK1HTR2B
SCHEMBL6227388 0.77 ALDH1A1 (0.53) RAB9AALDH1A1KDM4ECYP3A4TSHR
SCHEMBL17099553 0.76 CTNNB1 (0.38) CTNNB1WNT3ARAB9AALDH1A1SMN1; SMN2
SCHEMBL2169327 0.76 ALDH1A1 (0.41) RAB9AALDH1A1KDM4ECYP3A4TSHR
SCHEMBL6227310 0.74 CYP2C19 (0.55) HTR2BRAB9AALDH1A1KDM4ECYP3A4
SCHEMBL17440608 0.74 MAPK1 (0.40) FGFR1CTNNB1WNT3AMAPK1HTR2B
SCHEMBL17596974 0.72 PIM1 (0.48) FGFR1CTNNB1WNT3AMAPK1ROCK2
SCHEMBL2171309 0.71 DCAF1 (0.36) RAB9AALDH1A1SMN1; SMN2KDM4EHTT
SCHEMBL17593783 0.71 PDE4D (0.45) FGFR1CTNNB1WNT3ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015143376-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS NIVALIS THERAPEUTICS, INC. (US) 2015-09-24 WO disclosed